Stryker Corp (N:SYK)

Sector:  Healthcare Industry:  Medical Equipment, Supplies & Distribution
 
See Regulatory Filings on SEC
Company Contact
Address: 1941 STRYKER WAY
PORTAGE MI 49002
Tel: N/A
Website: https://www.stryker.com
IR: See website
<
Key People
Kevin A. Lobo
Chairman of the Board, President, Chief Executive Officer
Glenn S. Boehnlein
Chief Financial Officer, Vice President
Viju S. Menon
Group President - Global Quality and Operations
J. Andrew Pierce
Group President - MedSurg and Neurotechnology
Spencer S. Stiles
Group President - Orthopaedics and Spine
M. Kathryn Fink
Chief Human Resource Officer, Vice President
William E. Berry
Chief Accounting Officer, Vice President
Yin C. Becker
Vice President - Chief Corporate Affairs Officer
Robert S. Fletcher
Vice President, Chief Legal Officer
Business Overview
Stryker Corporation (Stryker) is a medical technology company. It offers products and services in Medical and Surgical, Neurotechnology, Orthopedics and Spine that help improve patient and healthcare outcomes. It operates through two segments: MedSurg and Neurotechnology, and Orthopedics and Spine. Its products include surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling, emergency medical equipment and intensive care disposable products; clinical communication and workflow solutions; neurosurgical and neurovascular devices; implants used in joint replacement and trauma surgeries; Mako Robotic-Arm Assisted technology; spinal devices; as well as other products. It also develops neurointerventional devices for the treatment of intracranial aneurysms. It offers Fortress, a modular wall system for hospitals and ambulatory surgery centers. It specializes in soft tissue fixation products and delivering AI-assisted virtual care workflows.
Financial Overview
For the six months ended 30 June 2024, Stryker Corp revenues increased 9% to $10.67B. Net income increased 21% to $1.61B. Revenues reflect MedSurg and Neurotechnology segment increase of 10% to $6.12B, Orthopaedics and Spine segment increase of 8% to $4.55B, United States segment increase of 10% to $7.96B, International segment increase of 6% to $2.7B. Net income benefited from MedSurg and Neurotechnology segment income increase of 18% to $1.67B.
Employees: 52,000 as of Dec 31, 2023
Reporting Currency: U.S. Dollars
Enterprise value: $144,080M as of Jun 30, 2024
Annual revenue (TTM): $21,389M as of Jun 30, 2024
EBITDA (TTM): $5,671M as of Jun 30, 2024
Net annual income (TTM): $3,448M as of Jun 30, 2024
Free cash flow (TTM): $1,624M as of Jun 30, 2024
Net Debt Last Fiscal Year: $10,265M as of Jun 30, 2024
Shares outstanding: 381,100,000 as of Jun 30, 2024
Index Membership: S&P 500
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.